Q1 FY27 results: Revenue up 24%, PAT up 34%, EBITDA margin expands 226 bps
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare's Q1 FY27 consolidated revenue rose 24% YoY to about Rs 240 Cr, driven by 27% growth in pathology. EBITDA grew 34% to about Rs 77 Cr with margin expanding 226 bps to 32%. PAT jumped 34% to about Rs 51 Cr. Standalone PAT grew 39% YoY. Tests conducted rose 28% to 55.2 Mn, patients up 17% to 5.4 Mn. Active franchisees hit a record 11,730. Radiology revenue declined 4% due to exit from unprofitable centers, but EBITDA grew 23%. New labs opened in Muzaffarpur, Prayagraj, Kurnool.
Strong all-round performance with margin expansion, record franchisee additions, and healthy PAT growth signals robust business momentum.